BRCA2 Pancreatic Cancer clinical trials
15 active Pancreatic Cancer trials that test for BRCA2 in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
- APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
- The Cancer of the Pancreas Screening-5 CAPS5)Study
- A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
- Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- Pilot Study of Pancreatic Cancer Screening
- Pancreatic Cancer Screening for At-risk Individuals
- A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
- Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
- PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
- Pancreas Registry and High Risk Registry
- Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
← All Pancreatic Cancer trials
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.